Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.
about
Dual inhibition of canonical and noncanonical NF-κB pathways demonstrates significant antitumor activities in multiple myelomaA Fashi Lymphoproliferative Phenotype Reveals Non-Apoptotic Fas Signaling in HTLV-1-Associated NeuroinflammationTargeting HTLV-1 activation of NFκB in mouse models and ATLL patients.The diverse and complex roles of NF-κB subunits in cancer.Molecular hallmarks of adult T cell leukemia.Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP.
P2860
Inhibition of immune activation by a novel nuclear factor-kappa B inhibitor in HTLV-I-associated neurologic disease.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhibition of immune activatio ...... associated neurologic disease.
@ast
Inhibition of immune activatio ...... associated neurologic disease.
@en
Inhibition of immune activatio ...... associated neurologic disease.
@nl
type
label
Inhibition of immune activatio ...... associated neurologic disease.
@ast
Inhibition of immune activatio ...... associated neurologic disease.
@en
Inhibition of immune activatio ...... associated neurologic disease.
@nl
prefLabel
Inhibition of immune activatio ...... associated neurologic disease.
@ast
Inhibition of immune activatio ...... associated neurologic disease.
@en
Inhibition of immune activatio ...... associated neurologic disease.
@nl
P2093
P2860
P1433
P1476
Inhibition of immune activatio ...... associated neurologic disease.
@en
P2093
D Robert Sliskovic
Dibyadeep Datta
Dileep D Monie
Jeffrey Meshulam
Kathryn Bobb
Matthew J McCormick
Richard V Turner
Steven Jacobson
P2860
P304
P356
10.1182/BLOOD-2010-10-306571
P407
P577
2011-01-06T00:00:00Z